STIL and ovarian carcinoma: In several cancers with bad prognosis, STIL expression has been found up-regulation, including lung cancer (Goto et al., 2013), prostate adenocarcinoma (Wu et al., 2019), bladder cancer (Du et al., 2018), and ovarian cancers (Rabinowicz et al., 2017a).